Performance and validation of a tumor mutation profiling, based on artificial intelligence annotation, to assist oncology decision making.
Miguel Mitne‐Neto(Hospital Santa Paula), Elisa Napolitano Ferreira(AC Camargo Hospital), Monica Maria Stiepcich(Fleury S.A. (Brazil)), Alexandre Ricardo dos Santos Fornari(Fleury S.A. (Brazil)), Rodrigo Fernandes Ramalho(Fleury S.A. (Brazil)), Gabriela Rampazzo Valim(Fleury S.A. (Brazil)), Andre Yuji Oku(Fleury S.A. (Brazil)), Matheus Carvalho Bürger(Fleury S.A. (Brazil)), Ilka Lopes Santoro(Universidade Federal de São Paulo), Raquel Stabellini(Fleury S.A. (Brazil)), Maria Carolina Tostes Pintão(Fleury S.A. (Brazil)), Aloisio Souza Felipe-Silva(Fleury S.A. (Brazil)), David Santos Marco Antônio(Fleury S.A. (Brazil)), Luciana Peniche Moreira(Fleury S.A. (Brazil)), Gisele W. B. Colleoni(Universidade Federal de São Paulo), Luciana Guilhermino Pereira(Fleury S.A. (Brazil)), Otavio Jose Eulalio(Fleury S.A. (Brazil))
Cited by 0
Related Papers
A Mutation in the Vesicle-Trafficking Protein VAPB Causes Late-Onset Spinal Muscular Atrophy and Amyotrophic Lateral Sclerosis
|The American Journal of Human Genetics|2004|990
Downregulation of VAPB expression in motor neurons derived from induced pluripotent stem cells of ALS8 patients
|Human Molecular Genetics|2011|213
ATIC-ALK: A Novel Variant ALK Gene Fusion in Anaplastic Large Cell Lymphoma Resulting from the Recurrent Cryptic Chromosomal Inversion, inv(2)(p23q35)
|American Journal Of Pathology|2000|169